Compare AMRN & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRN | FT |
|---|---|---|
| Founded | 1989 | 1988 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.9M | 188.0M |
| IPO Year | 1998 | N/A |
| Metric | AMRN | FT |
|---|---|---|
| Price | $11.35 | $7.39 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | ★ 73.0K | 51.1K |
| Earning Date | 10-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.85% |
| EPS Growth | ★ 55.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $181,104,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.11 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.22 | N/A |
| 52 Week Low | $11.25 | $6.95 |
| 52 Week High | $17.31 | $8.35 |
| Indicator | AMRN | FT |
|---|---|---|
| Relative Strength Index (RSI) | 36.60 | 56.49 |
| Support Level | N/A | $6.95 |
| Resistance Level | $15.34 | $8.32 |
| Average True Range (ATR) | 0.47 | 0.10 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 1.63 | 64.10 |
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
Franklin Universal Trust is a closed-end management investment company whose primary investment objective is to provide high current income consistent with preservation of capital. Its secondary objective is growth of income through dividend increases and capital appreciation. The company invests mainly in two asset classes: high-yield bonds and utility stocks. Its high-yield bond portfolio consists of a diversified portfolio of bonds selected through fundamental research, while its utility stock portfolio focuses on companies with attractive dividend yields and a history of increasing their dividends.